Biogen looks to build $1.1bn manufacturing plant in Switzerland
Biotech company Biogen plans to invest one billion Swiss francs ($1.1bn) in Solothurn, Switzerland to build a new production plant that will create about 400 new jobs beginning in 2019.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs